- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.07. | Integrum AB: Integrum receives additional custom duty refund of approximately SEK 3.3 million | 155 | GlobeNewswire (Europe) | Mölndal, Sweden, July 28, 2026 -Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has received a second refund of approximately SEK 3.3 million from U.S.... ► Artikel lesen | |
| 23.06. | Ursula Burns, Founder of Integrum, Chairwoman of Teneo, and Former CEO of Xerox Corporation, Elected as New Chair of the Ford Foundation Board of Trustees | 666 | PR Newswire | NEW YORK, June 23, 2026 /PRNewswire/ -- The Ford Foundation announced today the election of Ursula Burns as the new chair of its Board of Trustees. Burns will become the 13th board chair... ► Artikel lesen | |
| 16.06. | Integrum AB: Integrum receives customs duty refund of approximately SEK 2.6 million | 716 | GlobeNewswire (Europe) | Mölndal, Sweden, June 16, 2026 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has received an initial refund of approximately SEK 2.6 million from... ► Artikel lesen | |
| INTEGRUM Aktie jetzt für 0€ handeln | |||||
| 09.06. | Integrum AB: Integrum intends to incorporate all operations within bionics under the name Afyri | 687 | GlobeNewswire (Europe) | Mölndal, Sweden, June 9, 2026 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that it intends to consolidate all operations within bionics, including e-OPRA, are to... ► Artikel lesen | |
| 04.06. | Integrum meldet Umsatzrückgang im 4. Quartal trotz Rekordzahl an Operationen | 2 | Investing.com Deutsch | ||
| 04.06. | Integrum AB: Year-end Report 2025/2026 | 268 | GlobeNewswire (Europe) | Mölndal, June 4th 2026 - Integrum (publ) today publishes its year-end report for 2025/26.
Highlights of the fourth quarterThe number of S1 surgeries performed reached the highest level in the company's... ► Artikel lesen | |
| 30.04. | Integrum AB: Integrum implements a write-down of approximately SEK 7 million following reclassification of certain inventory items | 420 | GlobeNewswire (Europe) | Mölndal, Sweden, April 30, 2026 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that, as part of preparing the annual financial statements for the 2025/2026 fiscal year... ► Artikel lesen | |
| 15.04. | Integrum AB: Integrum accelerates Ukraine expansion following landmark decision to expand osseointegration treatment in national healthcare | 273 | GlobeNewswire (Europe) | Mölndal, Sweden, April 15, 2026 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces the appointment of Victoria Boiko to coordinate the company's commercial activities in... ► Artikel lesen | |
| 05.03. | Integrum AB: Integrum publishes Interim Report for the third quarter 2025/26 | 249 | GlobeNewswire (Europe) | Mölndal, 5 March 2026 - Integrum (publ) today publishes its interim report for the third quarter 2025/26. During the quarter, the structural transformation was completed and the company now enters the... ► Artikel lesen | |
| 03.03. | INTEGRUM AB: Integrum invites to presentation of Q3 2025/26 results | 5 | Cision News | ||
| 11.02. | Integrum AB: Integrum optimizes organization to further accelerate commercialization of OPRA Implant System | 500 | GlobeNewswire (Europe) | Mölndal, Sweden, February 11, 2026 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) announces today that the company is implementing organizational changes to accelerate the commercialization... ► Artikel lesen | |
| 02.12.25 | Integrum AB: Integrum's rights issue oversubscribed | 266 | GlobeNewswire (Europe) | Integrum AB (publ) ("Integrum" or the "Company") announced on October 16, 2025 that the Board of Directors had resolved to carry out an issue of shares of series B with preferential right for existing... ► Artikel lesen | |
| 21.11.25 | Integrum AB: Integrum publishes Interim Report for Q2 2025/26 | 258 | GlobeNewswire (Europe) | Second Quarter 2025/26 (August - October)
Net sales amounted to SEK 22.3 (21.8) million.
Operating result totalled SEK -11.1 (-11.3) million.
Profit/loss after tax amounted to SEK -7.4 (-8.9)... ► Artikel lesen | |
| 19.11.25 | True gibt neue Investitionspartnerschaft mit Integrum bekannt, um die Zukunft der Führungskräftevermittlung neu zu definieren | 407 | Business Wire | True, die weltweit führende Plattform für Führungskräfte, die die technologische Entwicklung der Branche durch Daten, KI und Fachwissen vorantreibt, hat heute eine neue strategische Investitionspartnerschaft... ► Artikel lesen | |
| 13.11.25 | Integrum AB: Integrum publishes preliminary financial key figures for the second quarter 2025/26 | 248 | GlobeNewswire (Europe) | Mölndal, 13 November 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B), today publishes, in connection with the ongoing rights issue, preliminary and unaudited financial key figures... ► Artikel lesen | |
| 11.11.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 11.11.2025 | 668 | Xetra Newsboard | Das Instrument TE5 SE0009806045 TERRANET AB B EQUITY wird ex Kapitalmassnahme gehandelt am 11.11.2025 The instrument TE5 SE0009806045 TERRANET AB B EQUITY is traded ex capital adjustment on 11.11.2025Das... ► Artikel lesen | |
| 10.11.25 | Integrum AB: Integrum enters into bridge loan agreement to cover short-term working capital needs | 247 | GlobeNewswire (Europe) | Integrum AB (publ) ("Integrum" or the "Company") has today entered into an agreement for a bridge loan of up to SEK 7 million with Buntel AB. The purpose of the loan is to cover the Company's short-term... ► Artikel lesen | |
| 23.10.25 | Integrum AB: Integrum announces organizational restructuring to strengthen its commercial focus | 367 | GlobeNewswire (Europe) | Mölndal, Sweden, October 23, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announced a strategic organizational restructuring to accelerate the commercialization of OPRA... ► Artikel lesen | |
| 20.10.25 | Integrum AB: Integrum announces that the Swedish Securities Council has published a statement regarding the takeover offer for Integrum | 303 | GlobeNewswire (Europe) | Mölndal, Sweden, October 20, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) notes that, in statement 2025:45 dated October 17, 2025, the Swedish Securities Council (Aktiemarknadsnämnden)... ► Artikel lesen | |
| 16.10.25 | Integrum AB: Integrum provides operational update ahead of Q2 report | 298 | GlobeNewswire (Europe) | Mölndal, Sweden, October 16, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today provides an operational update. Following the recent non-completed bid process, Integrum is taking... ► Artikel lesen |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 321,50 | +0,33 % | Intuitive Surgical: Exzellentes Geschäftsmodell, aber ist die Aktie jetzt zu teuer? | Intuitive Surgical gilt als Qualitätsunternehmen mit dominierender Marktstellung in der roboterassistierten Chirurgie, doch die aktuelle Bewertung der Aktie erscheint angesichts der jüngsten Kennzahlen... ► Artikel lesen | |
| MEDTRONIC | 79,76 | +0,10 % | Medtronic: What Experts Really Say About Overactive Bladder | Breaking down the myths, realities, and innovations shaping pelvic healthcare today. NORTHAMPTON, MA / ACCESS Newswire / August 18, 2026 / Bladder leaks, frequent trips to the bathroom, and pelvic discomfort... ► Artikel lesen | |
| THERMO FISHER | 535,60 | -0,67 % | Medtronic vs. Thermo Fisher: Which Healthcare Turnaround Offers More Upside? | ||
| STRATEC | 22,700 | +1,57 % | Stratec: Setzt sich der Trend fort? | Im ersten Halbjahr sinkt der Umsatz bei Stratec um 5,1 Prozent auf 112,53 Millionen Euro. Allerdings zeigt sich im zweiten Quartal eine positive Entwicklung. Ein Plus von 1,5 Prozent bedeutet einen... ► Artikel lesen | |
| HIMS & HERS HEALTH | 26,680 | +0,15 % | Aktien New York: Chipwerte belasten Nasdaq - US-Pläne gegen Iran bewegen kaum | NEW YORK (dpa-AFX) - Technologieaktien haben am Montag in den USA erneut geschwächelt. Standardwerte legten dagegen überwiegend moderat zu. Negative Vorgaben aus Asien, die am Mittwoch nachbörslich... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 73,74 | +0,55 % | Eurofins: Weekly Report on Share Repurchases From 17th August to 21st August 2026 | Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily... ► Artikel lesen | |
| BECTON DICKINSON | 165,40 | +1,13 % | What's Going On With Becton Dickinson Stock Wednesday? | ||
| FAMICORD | 2,910 | 0,00 % | EQS-News: FamiCord AG wechselt mit Wirkung zum 19. August 2026 ins Scale Segment | EQS-News: FamiCord AG
/ Schlagwort(e): Zulassungsgenehmigung
FamiCord AG wechselt mit Wirkung zum 19. August 2026 ins Scale Segment
18.08.2026 / 09:27 CET/CEST
Für den... ► Artikel lesen | |
| GERATHERM MEDICAL | 2,530 | -1,94 % | EQS-AFR: Geratherm Medical AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Geratherm Medical AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Geratherm Medical AG: Vorabbekanntmachung... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 42,195 | +0,40 % | dailyAktien: Boston Scientific - Langfristiges Stärkesignal | ||
| SYNLAB | - | - | EQS-News: SYNLAB: Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients | EQS-News: SYNLAB
/ Key word(s): Miscellaneous
Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients
10.08.2026 / 09:00 CET/CEST
The... ► Artikel lesen | |
| PAUL HARTMANN | 201,00 | 0,00 % | Januar bis Juni 2026: PAUL HARTMANN steigert erneut Umsatz und Ergebnis | Heidenheim (ots) - - Erfolgreiches 1. Halbjahr: Umsatzerlöse steigen auf 1.252,0 Mio. EUR, organisches Umsatzwachstum von 3,3 %; bereinigtes EBITDA liegt mit 151,7 Mio. EUR um 25,9 Mio. EUR über Vorjahreswert-... ► Artikel lesen | |
| RESMED | 200,00 | +0,33 % | RESMED INC: Update - Dividend/Distribution - RMD | ||
| MCKESSON | 747,40 | -0,27 % | Is McKesson Stock Worth Buying as Growth Meets a Premium Valuation? | ||
| BAXTER | 22,560 | -0,70 % | Baxter erhöht maximales Rückkaufvolumen für Anleihen auf 600 Millionen US-Dollar |
INTEGRUM AB gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +1,13 % bei einem Aktienkurs von 0,716 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INTEGRUM AB finden Sie auf Wallstreet Online.